Yuly Bersudsky
- Biological Psychiatry top 2%
- Psychiatry and Mental health top 1%
- Bipolar Disorder and Treatment 45
- Schizophrenia research and treatment 12
- Electroconvulsive Therapy Studies 7
- Epilepsy research and treatment 6
- Behavioral Neuroscience top 5%
-
- Neuroscience and Neuropharmacology Research 6
-
- Pharmacological Effects and Toxicity Studies 11
-
- Genetics and Neurodevelopmental Disorders 10
-
- Treatment of Major Depression 6
Yuly Bersudsky
88 papers receiving 1.8k citations
Peers
Comparison fields: 5 of 108
- Biological Psychiatry 201
- Psychiatry and Mental health 916
- Behavioral Neuroscience 76
- Cellular and Molecular Neuroscience 317
- Pediatrics, Perinatology and Child Health 248
Countries citing papers authored by Yuly Bersudsky
This map shows the geographic impact of Yuly Bersudsky's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yuly Bersudsky with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yuly Bersudsky more than expected).
Fields of papers citing papers by Yuly Bersudsky
This network shows the impact of papers produced by Yuly Bersudsky. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yuly Bersudsky. The network helps show where Yuly Bersudsky may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Yuly Bersudsky, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 5 | |
| 2 | 2020 | 7 | |
| 3 | 2019 | 8 | |
| 4 | A pilot open study of long term high dose creatine augmentation in patients with treatment resistant negative symptoms schizophrenia. | 2015 | 5 |
| 5 | 2015 | 3 | |
| 6 | 2013 | 68 | |
| 7 | 2008 | 33 | |
| 8 | 2008 | 21 | |
| 9 | 2007 | 42 | |
| 10 | 2007 | 7 | |
| 11 | 2007 | 45 | |
| 12 | 2007 | 19 | |
| 13 | 2006 | 11 | |
| 14 | 2005 | 10 | |
| 15 | 2005 | 80 | |
| 16 | 2005 | 15 | |
| 17 | 2005 | 2 | |
| 18 | 2005 | 10 | |
| 19 | 2004 | 18 | |
| 20 | 2002 | 15 |
About Yuly Bersudsky
Yuly Bersudsky is a scholar working on Psychiatry and Mental health, Biological Psychiatry and Pharmacology, having authored 89 papers that have together received 1.8k indexed citations. Recurring topics across this work include Bipolar Disorder and Treatment (45 papers), Schizophrenia research and treatment (12 papers), Pharmacological Effects and Toxicity Studies (11 papers), Genetics and Neurodevelopmental Disorders (10 papers), Electroconvulsive Therapy Studies (7 papers), Neuroscience and Neuropharmacology Research (6 papers), Epilepsy research and treatment (6 papers) and Treatment of Major Depression (6 papers). The work is most often cited by research in Biological Psychiatry (201 citations), Psychiatry and Mental health (916 citations) and Behavioral Neuroscience (76 citations). Yuly Bersudsky has collaborated with scholars based in Israel, United States and Russia. Frequent co-authors include Robert H. Belmaker, Yamima Osher, R.H. Belmaker, Galila Agam, Alona Shaldubina, Galila Agam, Alexander Mishory, Ora Kofman, Galila Agam and Gerard T. Berry. Their work appears in journals such as American Journal of Psychiatry, Scientific Reports and Biological Psychiatry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.